Established Expertise CMAX Clinical Research is a well-established leader in early-phase clinical trials in Australia, with over 30 years of experience and a robust track record of over 200 first-in-human studies, indicating reliability and high-quality research capabilities.

Global Regulatory Compliance The company's adherence to international standards such as ICH GCP and compliance with agencies including US FDA, EMEA, Japan's MHW, and Health Canada positions it as a trusted partner for multinational pharmaceutical companies seeking compliant and high-standard clinical trials.

Expansive Participant Database With access to a diverse database of over 65,000 participants and a state-of-the-art 78-bed facility, CMAX can efficiently support large and complex early-phase studies, offering potential for accelerated trial recruitment for new client portfolios.

Recent Strategic Partnerships The partnership with Holoclara Inc and collaborative projects with global organizations suggest opportunities to leverage existing relationships for expanding services, especially in emerging therapeutic areas like advanced biotechnologies and personalized medicine.

Growth and Market Position Operating within the Australian research services sector with revenue estimated between 1 million to 10 million USD and employing up to 500 staff, CMAX presents a compelling opportunity for service providers aiming to expand into the Asia-Pacific region or to offer complementary solutions in clinical trial management and participant recruitment.